Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized study of Kaletra versus Kaletra + Combivir in antiretroviral-naive HIV-1 patients
2004-000816-24Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lopinavir + ritonavir in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Virologic response at Weeks 24, 48, and 96. Started Oct 2004; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2004-000816-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000816-24.